Bio Roundup: RIP Roger Tsien, Novartis CAR-T Wheel, Zika News & More
Xconomy
SEPTEMBER 2, 2016
—Cambridge, MA-based messenger RNA drug developer Moderna Therapeutics is raising another huge financing round, according to an SEC filing. —Cambridge-based Biogen (NASDAQ: BIIB ) published the results of an early stage study of closely watched Alzheimer’s disease drug aducanumab in the journal Nature.
Let's personalize your content